Bloomberg News

Krka Opens Drug-Manufacturing Center in Novo Mesto, Slovenia

October 27, 2011

Oct. 27 (Bloomberg) -- Krka Group d.d., Slovenia’s biggest pharmaceutical company, opened a drug-making unit in Novo mesto in an investment worth 91 million euros ($128 million). The Novo mesto-based company commented in an e-mailed statement today.

The facility will be able to produce up to 2.5 billion pills a year, it said.

To contact the reporter on this story: Boris Cerni in Ljubljana at bcerni@bloomberg.net

To contact the editor responsible for this story: Douglas Lytle at dlytle@bloomberg.net


Toyota's Hydrogen Man
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus